Latest news for Global Health Clinics (OTC:LRSNF) Stock

Global Health Clinics Ltd engages in the cannabis industry and operates medical clinics which guide patients through the process of becoming legal users of marijuana and also engages in developing psilocybin products for research and their potential usage for pharmaceutical purposes. The Company operates in two operating segments the operating of medical clinics to guide patients to become legal users of marijuana and the development of psilocybin products for research and potential usage for pharmaceutical purposes. The Company derives its key revenue from Medical Clinics for legal user of Marijuana.

News

Intraday Update

Markets

Movers

Trading Ideas

AGEEF

AKTAF

BCOV

BNNLF

BSAC

BTTR

CASI

CCOZF

CEIX

CGAAY

CGCO

CGRA

CJPRY

CLSH

CTRM

CWBHF

CYBQF

DLUEY

DNTUY

ECOL

EJPRY

ERMAY

EUOT

FEIM

GDNEF

GFGSF

GGLT

GNMK

GPHBF

GSUM

GWRRF

HBCYF

HBRM

HZNFF

ITCB

JAPAY

JAPSY

JGFCF

KMTUY

KPCPY

LFAP

LIVE

LNTH

LRSNF

MALJF

MBGRF

MFMLF

MOBQ

MSPC

MZDAY

NDBKY

NGVC

NINOY

NODK

OSUR

PDPYF

PLPRF

PETROTEQ ENERGY INC by Petroteq Energy Inc.

PQEFF

QEGY

RCON

RDS-B

RMTD

RSSV

RWLK

RYKKY

SCIE

SHMDF

SRDX

STAY

TARO

TBLMY

TOPS

TOSYY

TRNX

TVTY

UBQU

UBSI

UNEQ

USGDF

Stocks That Hit 52-Week Lows On Thursday

Movers & Shakers

General

ADAP

ADGO

AEYE

AIHS

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

ANDE

APEI

Adtalem Global Education Inc. Common Stock

ATGE

ATVK

AXAS

AXTI

BARRF

BBIO

BCDS

BIOL

BLFR

BRSWQ

BRTX

BTCS

BTLLF

CCAN

CCRC

CDEV

CELLCUBE ENERGY STORAGE by Cellcube Energy Storage Sys Inc.

CECBF

CELC

CGNSF

CHCX

CLVS

CMCT

CNONF

CNSL

COBALT BLOCKCHAIN INC by Cobalt Blockchain Inc.

COBCF

CRTPF

CRUUF

CRYCY

DKAM

DLOC

ELOX

EMESQ

EWLL

EZCL

FSDDF

FUAPF

GALXF

GEMP

GNFT

GNFTF

GRTD

HAON

HTBX

HUTN

INMB

IRNC

JAGX

KALV

KOIOS BEVERAGE CORP by Koios Beverage Corp.

KBEVF

LIVX

LRTTF

LTMCF

MAKSY

MAYS

MINE

MMMM

MORF

MRNJ

MARICANN GROUP INC ORD by Maricann Group Inc

MRRCF

MRSN

MYMMF

MYOV

NANX

NEOM

NMTC

NSPXD

NUGS

OMAG

PBBSF

PEYUF

PGPEF

PHMB

PNAT

PPSI

PRPM

PTAIF

RTIX

SCON

SLCA

SPLIF

Stocks That Hit 52-Week Lows Of Monday

GLOBAL HEALTH CLINICS LTD by Global Health Clinics Ltd.

Global Health Clinics Ltd

HC Wainwright &amp; Co. analyst Arthur He reiterates Adagene (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAG#NASDAQ">ADAG</a>) with a Buy and maintains $5 price target.

Price Target

Reiteration

Analyst Ratings

ADAG

HC Wainwright & Co. Reiterates Buy on Adagene, Maintains $5 Price Target

The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) disclosed that it forecasts a 3% increase in airplane deliveries over the next 20 years, estimating a need for nearly 44,000 <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/n39869384/boeing-forecasts-demand-for-nearly-44-000-new-airplanes-through-2043-as-air-travel-surpasses-pre-p" rel="noreferrer noopener">new commercial airplanes by 2043</a>.
The global commercial fleet is expected to grow at an annual rate of 3.2%, slower than air traffic growth, as airlines enhance productivity by raising load factors and utilizing <a target="_blank" href="https://www.benzinga.com/calendars/guidance" rel="noreferrer noopener">airplanes for more hours each day</a>.
Boeing expects that emerging markets and global single-aisle market demand will be the main growth drivers for the industry.
By geographies, Boeing projects South Asia&#8217;s passenger traffic to grow by 7.4%, followed by Southeast Asia at 7.2% and Africa at 6.4%. Also, Eurasia will lead airplane deliveries with 22%, while North America and China will each account for 20%.
By 2043, single-aisle airplanes will comprise 71% of the fleet with 33,380 new deliveries, mainly for short- to medium-haul routes.
Read: <a target="_blank" href="https://www.benzinga.com/news/24/07/39818420/boeings-737-max-crisis-ripple-effects-disrupt-airlines-suppliers" rel="noreferrer noopener">Boeing&#8217;s 737 MAX Crisis Ripple Effects Disrupt Airlines, Suppliers</a>
The 2024 Commercial Market&nbsp;Outlook (CMO) forecasts that passenger air traffic will increase by an average of 4.7% annually over the next two decades compared to 2023.
Dan Abraham, senior vice president of Boeing Global Services Commercial Sales and Marketing, commented, &#8220;As airlines respond to robust passenger demand, the services market continues to expand, not only as a result of fleet growth, but also with an increased focus on reducing operating costs and deploying efficient and sustainable solutions.&#8221;&nbsp;
Also Read: <a target="_blank" href="https://www.benzinga.com/markets/equities/24/07/39788122/judge-allots-time-for-boeing-737-max-crash-victims-relatives-to-object-plea-deal-report" rel="noreferrer noopener">Judge Allots Time For Boeing 737 MAX Crash Victims&#8217; Relatives To Object Plea Deal: Report</a>
Boeing forecasts a $4.4 trillion demand for commercial services, fueled by maintenance, modifications, and digital solutions that enhance efficiency.
Today, Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>) has been chosen to supply rotary actuation solutions for NASA and Boeing&#8217;s Transonic Truss-braced Wing (TTBW) <a target="_blank" href="https://www.benzinga.com/pressreleases/24/07/g39876628/boeing-selects-woodward-to-design-innovative-rotary-actuator-for-the-nasa-sustainable-flight-demon" rel="noreferrer noopener">X-66A aircraft demonstrator</a>.
Last week, Boeing faced yet another challenge as Washington state factory workers voted overwhelmingly in favor of a strike mandate, amid the workers&#8217; demand for a 40% raise during their first <a target="_blank" href="https://www.benzinga.com/news/24/07/39836988/boeing-workers-vote-for-strike-mandate" rel="noreferrer noopener">full&nbsp;negotiation with Boeing&nbsp;in 16 years</a>.
Boeing stock has lost more than 16% in the last 12 months.&nbsp;Investors can gain exposure to the stock via&nbsp;IShares U.S.&nbsp;Aerospace &amp; Defense ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/ITA#BATS">ITA</a>) and&nbsp;Invesco Aerospace&nbsp;&amp; Defense ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PPA#NYSE">PPA</a>).
Price Action: BA shares are up 0.46% at $180.50 premarket at the last check Monday.
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Photo Courtesy: Tada Images On Shutterstock.com
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/07/39810693/boeing-delivers-critical-core-stage-for-nasas-lunar-mission-details" target="_blank" rel="noreferrer noopener">Boeing Delivers Critical Core Stage for NASA&#8217;s Lunar Mission: Details</a></li>
</ul>

Equities

Large Cap

Guidance

iShares Dow Jones US Aerospace & Defense Index Fund

Boeing's Commercial Market Outlook Predicts Soaring Demand: 44,000 New Airplanes Needed By 2043

On July 19, 2024, Allarity Therapeutics, Inc. (the &ldquo;Company&rdquo;) received a &ldquo;Wells Notice&rdquo; from the Staff of the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;) relating to the Company&rsquo;s previously disclosed SEC investigation. The Wells Notice relates to the Company&rsquo;s disclosures regarding meetings with the United States Food and Drug Administration (the &ldquo;FDA&rdquo;) regarding the Company&rsquo;s NDA for Dovitinib or Dovitinib-DRP, which was submitted to the FDA in 2021. The Company understands that all conduct relating to the SEC Wells Notice occurred during or prior to fiscal year 2022. Allarity also understands that three of its former officers received Wells Notices from the SEC relating to the same conduct. A Wells Notice is neither a formal charge of wrongdoing nor a final determination that the recipient has violated any law. The Wells Notice informed the Company that the SEC Staff has made a preliminary determination to recommend that the SEC file an enforcement action against the Company that would allege certain violations of the federal securities laws. The Company is continuing to cooperate with the SEC and maintains that its actions were appropriate, and intends to pursue the Wells Notice process, including submitting a formal response to the SEC.

Government

Regulations

SEC Issues Wells Notice to Allarity Therapeutics and Former Officers Over 2021 FDA NDA Submission

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comments

Global Health Clinics

News

Latest news for Global Health Clinics (OTC:LRSNF) Stock

Monday, April 29, 2024

Thursday, February 20, 2020

Monday, October 07, 2019